City Therapeutics, Inc. Common Stock (CTY) is a publicly traded the market company. As of October 20, 2026, CTY trades at $21.44 with a market cap of $1.13B and a P/E ratio of 0.00. CTY moved -4.02% today. Year to date, CTY is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $20.50 to $23.88. Rallies surfaces CTY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for CTY shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $21.44 |
| Market Cap | $1.13B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.37% |
| 52-Week High | $23.88 |
| 52-Week Low | $20.50 |
| Volume | 279.41K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
CTY analyst coverage data. Average price target: $0.00.